These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1808803)

  • 1. Autosomal dominant retinitis pigmentosa with rhodopsin, valine-345-methionine.
    Berson EL; Sandberg MA; Dryja TP
    Trans Am Ophthalmol Soc; 1991; 89():117-28; discussion 128-30. PubMed ID: 1808803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Dryja TP
    Am J Ophthalmol; 1991 May; 111(5):614-23. PubMed ID: 2021172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant retinitis pigmentosa in a large family: a clinical and molecular genetic study.
    Rosas DJ; Roman AJ; Weissbrod P; Macke JP; Nathans J
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3134-44. PubMed ID: 8045708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular findings in a form of retinitis pigmentosa with a rhodopsin gene defect.
    Berson EL
    Trans Am Ophthalmol Soc; 1990; 88():355-88. PubMed ID: 2095030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in the NRL gene and associated clinical findings in patients with dominant retinitis pigmentosa.
    DeAngelis MM; Grimsby JL; Sandberg MA; Berson EL; Dryja TP
    Arch Ophthalmol; 2002 Mar; 120(3):369-75. PubMed ID: 11879142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Description of a new mutation in rhodopsin, Pro23Ala, and comparison with electroretinographic and clinical characteristics of the Pro23His mutation.
    Oh KT; Weleber RG; Lotery A; Oh DM; Billingslea AM; Stone EM
    Arch Ophthalmol; 2000 Sep; 118(9):1269-76. PubMed ID: 10980774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn.
    Wada Y; Sandberg MA; McGee TL; Stillberger MA; Berson EL; Dryja TP
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1735-41. PubMed ID: 15851576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of Japanese family with autosomal dominant retinitis pigmentosa caused by point mutation in codon 347 of rhodopsin gene.
    Shiono T; Hotta Y; Noro M; Sakuma T; Tamai M; Hayakawa M; Hashimoto T; Fujiki K; Kanai A; Nakajima A
    Jpn J Ophthalmol; 1992; 36(1):69-75. PubMed ID: 1635298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular findings associated with rhodopsin gene codon 17 and codon 182 transition mutations in dominant retinitis pigmentosa.
    Fishman GA; Stone EM; Sheffield VC; Gilbert LD; Kimura AE
    Arch Ophthalmol; 1992 Jan; 110(1):54-62. PubMed ID: 1731723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation.
    Rosenfeld PJ; Hahn LB; Sandberg MA; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2186-92. PubMed ID: 7558711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His).
    Berson EL; Rosner B; Sandberg MA; Dryja TP
    Arch Ophthalmol; 1991 Jan; 109(1):92-101. PubMed ID: 1987956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa.
    Sandberg MA; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1934-42. PubMed ID: 7635666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new codon 15 rhodopsin gene mutation in autosomal dominant retinitis pigmentosa is associated with sectorial disease.
    Sullivan LJ; Makris GS; Dickinson P; Mulhall LE; Forrest S; Cotton RG; Loughnan MS
    Arch Ophthalmol; 1993 Nov; 111(11):1512-7. PubMed ID: 8240107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of conserved rhodopsin disulfide bond by Cys187Tyr mutation causes early and severe autosomal dominant retinitis pigmentosa.
    Richards JE; Scott KM; Sieving PA
    Ophthalmology; 1995 Apr; 102(4):669-77. PubMed ID: 7724183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular findings in a family with autosomal dominant retinitis pigmentosa and a frameshift mutation altering the carboxyl terminal sequence of rhodopsin.
    Apfelstedt-Sylla E; Kunisch M; Horn M; Rüther K; Gerding H; Gal A; Zrenner E
    Br J Ophthalmol; 1993 Aug; 77(8):495-501. PubMed ID: 8025047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant retinitis pigmentosa with a rhodopsin mutation (Arg-135-Trp). Disease phenotype in a Swedish family.
    Ponjavic V; Abrahamson M; Andréasson S; Ehinger B; Fex G
    Acta Ophthalmol Scand; 1997 Apr; 75(2):218-23. PubMed ID: 9197578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa.
    Sandberg MA; Weigel-DiFranco C; Rosner B; Berson EL
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1693-8. PubMed ID: 8675413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular manifestations in autosomal dominant retinitis pigmentosa with a Lys-296-Glu rhodopsin mutation at the retinal binding site.
    Owens SL; Fitzke FW; Inglehearn CF; Jay M; Keen TJ; Arden GB; Bhattacharya SS; Bird AC
    Br J Ophthalmol; 1994 May; 78(5):353-8. PubMed ID: 8025068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.